Descrição

Injectables refer to drug delivery system which acts as an alternative to oral drugs. As injectables are rapidly inserted into the human body using a syringe, they bypass the first-pass metabolism. The global generic injectables market is poised to grow by US$ 49.3 bilhão de 2022 para 2028, registrando um CAGR de 8.7% durante o período de previsão, de acordo com StrategyHelix.

O relatório fornece dados atualizados sobre o tamanho do mercado para o período 2018-2021 e previsão para 2028 covering key market aspects like sales value for generic injectables. The global generic injectables market is segmented on the basis of product, route of administration, aplicativo, and region. Por produto, the global generic injectables market has been segmented into large molecule, small molecule. Based upon route of administration, the global generic injectables market is categorized into intravenous (IV) generic injectables, intramuscular (IM) generic injectables, subcutaneous (SC) generic injectables, outros. On the basis of application, the global generic injectables market has been segmented into oncology, infectious diseases, cardiology, diabetes, immunology, outros. In terms of geography, the global generic injectables market has been segmented into Asia Pacific, Europa, América do Norte, Rest of the World (RoW).

The global generic injectables market is highly competitive. Top players covered in Global Generic Injectables Market Study are AstraZeneca plc, Baxter International Inc., Dr.. Reddy’s Laboratories Ltd., Fresenius SE & Co. KGaA, Hikma Pharmaceuticals plc, Lupin Limited, Merck & Co. Inc., Mylan N.V., Pfizer Inc.

O relatório é um recurso inestimável para empresas e organizações ativas neste setor. It provides a cohesive picture of the generic injectables market to help drive informed decision making for industry executives, decisores políticos, acadêmico, e analistas.

Escopo do relatório

produtos: large molecule, small molecule
Route of administration: intravenous (IV) generic injectables, intramuscular (IM) generic injectables, subcutaneous (SC) generic injectables, outros
Aplicativo: oncology, infectious diseases, cardiology, diabetes, immunology, outros
Região: Ásia-Pacífico, Europa, América do Norte, Rest of the World (RoW)
Anos considerados: este relatório cobre o período 2018 para 2028

Principais benefícios para as partes interessadas

– Get a comprehensive picture of the global generic injectables market
– Identifique setores de crescimento e tendências para investimento

Índice

Papel 1. Introdução
– Escopo do estudo
– Período de estudos
– Escopo geográfico
– Metodologia de Pesquisa
Papel 2. Generic injectables market overview
Papel 3. Divisão de mercado por produto
– Large molecule
– Small molecule
Papel 4. Market breakdown by route of administration
– Intravenous (IV) generic injectables
– Intramuscular (IM) generic injectables
– Subcutaneous (SC) generic injectables
– Outros
Papel 5. Market breakdown by application
– Oncology
– Infectious diseases
– Cardiology
– Diabetes
– Immunology
– Outros
Papel 6. Market breakdown by region
– Ásia-Pacífico
– Europa
– América do Norte
– Rest of the World (RoW)
Papel 7. Principais empresas
– AstraZeneca plc
– Baxter International, Inc..
– Dr.. Reddy’s Laboratories Ltd.
– Fresenius SE & Co. KGaA
– Hikma Pharmaceuticals plc
– Lupin Limited
– Merck & Co., Inc..
– Mylan N.V.
– Pfizer, Inc.
Sobre StrategyHelix
Isenção de responsabilidade